RESTON, Va., Oct. 30, 2020 /PRNewswire/ — SOC Telemed, Inc. (“SOC”), one of many largest nationwide suppliers of acute care telemedicine, right now introduced that it has accomplished its beforehand introduced enterprise mixture with Healthcare Merger Corp. (“HCMC”) (NASDAQ: HCCO), a particular function acquisition firm. The enterprise mixture was accredited at a particular assembly of HCMC’s stockholders on October 30, 2020 and closed on October 30, 2020. The shares of Class A standard inventory and warrants to buy shares of Class A standard inventory of SOC Telemed are anticipated to start buying and selling on the Nasdaq on November 2, 2020, below the image “TLMD” and “TLMDW,” respectively.
SOC Telemed is now led by John Kalix, Chief Govt Officer, and Hai Tran, Chief Working Officer and Chief Monetary Officer. Steve Shulman, the previous Chief Govt Officer and a director of HCMC, is now the Chairman of the SOC Telemed board of administrators.
“In the present day marks an essential milestone for SOC Telemed in our pursuit of delivering speedy entry to digital specialty care when sufferers are at their most susceptible,” mentioned John Kalix, Chief Govt Officer of SOC Telemed. “Digital care is a essential element of right now’s healthcare {industry} and SOC Telemed is properly positioned to speed up its penetration of the broad and fast-growing acute telemedicine market. I’m assured in our capacity to broaden and profit from the tendencies which are driving speedy adoption of telemedicine.”
Steve Shulman, Chairman of the SOC Telemed board of administrators weighed in on the workforce that supported right now’s enterprise mixture: “You will need to acknowledge the management and counsel over the previous 12 months of our interim CEO, Paul Ricci who helped information us via the months main as much as right now’s closing.”
“In the present day marks an amazing alternative for the SOC Telemed workforce and the way forward for digital care,” mentioned Paul Ricci who served as interim CEO throughout the time period that led as much as the proposed enterprise mixture. He continued, “With its stable expertise platform, an enhanced management workforce and now speedy entry to capital, SOC Telemed is able to serve the continued demand for acute telemedicine.”
Credit score Suisse served as monetary advisor to SOC and acted as placement agent on the personal providing. Baird and William Blair served as capital markets advisors to SOC. H2C Securities served as placement agent on the personal placement with strategic healthcare programs. Orrick Herrington & Sutcliffe LLP served as authorized counsel to SOC. MTS Well being Companions, L.P. served as monetary advisor and Weil, Gotshal & Manges LLP and Ellenoff Grossman & Schole LLP served as authorized counsel to HCMC. Cantor Fitzgerald & Co. served as capital markets advisor to HCMC.
About SOC
SOC Telemed (SOC) is the most important nationwide supplier of telemedicine expertise and options to hospitals, well being programs, post-acute suppliers, doctor networks, and value-based care organizations. Constructed on confirmed and scalable infrastructure as an enterprise-wide answer, SOC’s expertise platform, Telemed IQ, quickly deploys and seamlessly optimizes telemedicine applications throughout the continuum of care. SOC supplies a supportive and devoted accomplice presence, nearly delivering affected person care via teleNeurology, telePsychiatry and teleICU, enabling healthcare organizations to construct sustainable telemedicine applications in any medical specialty. SOC allows organizations to counterpoint their care fashions and contact extra lives by supplying healthcare groups with industry-leading options that drive improved medical care, affected person outcomes, and organizational well being. The corporate was the primary supplier of acute medical telemedicine providers to earn The Joint Fee’s Gold Seal of Approval and has maintained that accreditation yearly since inception. For extra data, go to www.soctelemed.com.
Ahead-Wanting Statements
This press launch contains “forward-looking statements” inside the that means of the “protected harbor” provisions of the USA Non-public Securities Litigation Reform Act of 1995. Ahead-looking statements could also be recognized by means of phrases akin to “estimate,” “plan,” “potential,” “predict,” “undertaking,” “forecast,” “intend,” “could,” “ought to,” “would,” “will,” “anticipate,” “proceed,” “anticipate,” “consider,” “search,” “goal” or different related expressions that predict or point out future occasions or tendencies or that aren’t statements of historic issues. These forward-looking statements embrace, however usually are not restricted to, statements about market tendencies and SOC Telemed’s capacity to handle its alternative. These statements are based mostly on varied assumptions, whether or not or not recognized on this press launch, and on the present expectations of SOC Telemed’s administration and usually are not predictions of precise efficiency. These forward-looking statements are supplied for illustrative functions solely and usually are not supposed to function, and should not be relied on by any investor as, a assure, an assurance, a prediction or a definitive assertion of truth or likelihood. Precise occasions and circumstances are tough or inconceivable to foretell and can differ from assumptions. Many precise occasions and circumstances are past the management of SOC Telemed. These forward-looking statements are topic to a lot of dangers and uncertainties, together with modifications in enterprise, market, monetary, political and authorized situations; dangers associated to SOC Telemed’s enterprise, adoption of its software program platform and different issues; the consequences of competitors on SOC Telemed’s future enterprise; the potential antagonistic results of the continuing international COVID-19 pandemic on capital markets, normal financial situations, unemployment and SOC Telemed’s liquidity, operations and personnel; and people elements mentioned within the HCMC’s registration assertion on Type S-4 (No. 333-248097) below the heading “Danger Components,” filed with the SEC. If any of those dangers materialize or our assumptions show incorrect, precise outcomes may differ materially from the outcomes implied by these forward-looking statements. SOC Telemed doesn’t undertake any obligation to replace or revise any forward-looking statements, whether or not on account of new data, future occasions or in any other case, besides as required by legislation.
Media Relations:
Lauren Shankman
Trevelino/Keller
[email protected]
Investor Relations:
Bob East or Jordan Kohnstam
Westwicke, an ICR firm
[email protected]
(443) 213-0500
SOURCE SOC Telemed
